Analysts at BMO Capital Markets said Centessa’s orexin receptor agonist has “best-in-class” potential for narcolepsy, putting ...

Among patients with narcolepsy, AXS-12 (reboxetine) vs placebo significantly reduced the frequency of cataplexy attacks.

Jazz Pharmaceuticals said on Tuesday that it had agreed to a settlement of $145 million to resolve a series of antitrust lawsuits related to its narcolepsy drug, Xyrem. Xyrem, a medication approved in ...

研究结果表明，ON-SXB在治疗嗜睡症方面具有显著优势。在“Narcolepsy: beyond the classic pentad”一文中，研究者指出嗜睡症的症状谱远超经典的五联征，强调了全面评估的重要性。在“A survey of people living with narcolepsy in the US: path to diagnosis, quality of life, and ...

Jazz is being accused of anti-competitive practices regarding its narcolepsy drug, as generic competitors emerge on the ...

Jazz Pharma has agreed to pay $145 million to settle lawsuits claiming it illegally acted to prevent generic versions of its ...

Multiple sleep disorders can affect your energy levels, and two that often get confused for one another are narcolepsy and chronic fatigue syndrome. Though both chronic fatigue syndrome and ...

Further information The NICE-Wide Prioritisation Board met November 2024. The Prioritisation Board considered the technology at length. It recognised the difference in commissioning of narcolepsy ...

Avadel has initiated four patent infringement lawsuits against Jazz Pharmaceuticals since the beginning of 2025, alleging certain uses of Jazz’s Xywav product, according to its corresponding labeling, ...

Centessa Pharmaceuticals plc shifts focus to ORX750 for sleep disorders after discontinuing SerpinPC. Click here to find out ...